Nassiri et al. (34) used CytoSorb® in 26 patients with COVID-19-associated moderate ARDS (PaO2/FiO2 ratio <200) and hyper inflammation (CRP > 50 mg/L and ferritin > 1,500 mcg/L). The gene discussed is CRP; the disease is acute respiratory distress syndrome.